Please login to the form below

Not currently logged in
Email:
Password:

Ibuprofen could reduce Parkinson's risk

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

Regular use of OTC NSAIDs was associated with a 60 per cent reduction in the risk of developing Parkinson's disease, compared with occasional or non-use.

The study compared the use of aspirin and other NSAIDs in 579 men and women, half of whom had Parkinson's disease. Regular NSAID use was defined as taking two or more tablets a week for at least one month. Regular use of aspirin was associated with a 40 per cent reduction in risk, but only among women.

"Our findings suggest NSAIDs are protective against Parkinson's disease, with a particularly strong effect among regular users of non-aspirin NSAIDs, especially those who reported two or more years of use," commented study author Dr Anelika Wahner of the UCLA School of Public Health in Los Angeles.

The results are published in full in the 6 November 2007 issue of Neurology, the medical journal of the American Academy of Neurology.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics